Beyond complete myocardial revascularization: is it important and does it matter?

Michael Nathanson1, Kai Ihnken

  • 1Santa Clara Valley Medical Center, Division of Cardiothoracic Surgery, San Jose, CA 95128, USA. mnathanson@scvmc.org

Insights

Maximizing coronary artery bypass grafts beyond one per system is not supported by evidence for long-term freedom from adverse events. Current literature lacks detailed analysis of graft number versus outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Coronary artery bypass grafting (CABG) is a common treatment for coronary artery disease.
  • The practice of performing multiple grafts per coronary system (left anterior descending, circumflex, right) has been prevalent, aiming for long-term freedom from major adverse coronary events.
  • However, the scientific literature lacks robust documentation supporting the necessity of maximizing bypass grafts beyond one per system.

Purpose of the Study:

  • To evaluate the evidence supporting the practice of maximizing the number of coronary artery bypass grafts per system.
  • To identify limitations in existing literature regarding graft number and clinical outcomes.
  • To highlight the need for detailed analysis of revascularization strategies based on coronary anatomy.

Main Methods:

  • Review of existing medical and surgical literature on coronary artery bypass grafting.
  • Analysis of published series regarding patient cohorts, follow-up duration, and clinical endpoints.
  • Identification of gaps in studies stratifying outcomes by detailed coronary vessel anatomopathologic inventory and revascularization strategy.

Main Results:

  • The medical and surgical literature does not adequately document the importance of maximizing coronary artery bypass grafts beyond one per system.
  • Published studies show significant variation in patient populations, follow-up periods, and the range of clinical endpoints assessed.
  • No published series provide subset stratification analysis linking detailed coronary vessel pathology to revascularization strategy and outcomes.

Conclusions:

  • The presumed benefit of maximizing coronary artery bypass grafts per system is not well-supported by current evidence.
  • Existing literature is limited by heterogeneity and a lack of comprehensive endpoint analysis.
  • Further research is needed to analyze revascularization strategies based on detailed coronary anatomy and patient-specific factors.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...